Martin Wermke

18PUBLICATIONS
148CO-AUTHORS
Recordkeeping informaticsMolecular targetsTumour immunologyGene and molecular therapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 26, 2026
Deidentifying Medical Documents with Local, Privacy-Preserving Large Language Models: The LLM-Anonymizer.

|Oct 08, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.

|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial.

|Sep 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms.

Simone Thomas, Martin Wermke, Vladan Vučinić

|Sep 04, 2025
Histologic Transformation in Cancer: The Path for Clinical Translation.

Ioannis Vathiotis, Avisek Banerjee, Utsav Sen

|Jul 24, 2025
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas.

Martin Wermke, Valentina Gambardella, Yasutoshi Kuboki

Pageof 3

Frequent Collaborators

4 joint publications

Cedrik Michael Britten

4 joint publications

Norbert Hilf

3 joint publications

Jürgen Wolf

2 joint publications

Yael C Cohen